Optimization and Evaluation of Desloratadine Oral Strip: An Innovation in Paediatric Medication

Table 3

Physicochemical characterization of OS of DSL (𝑛=10).

Formulation code	Content (%)	Weight variation (%)	Thickness (mm)
F1	97.23	−2.83	0.21±0.02
F3	98.88	1.16	0.28±0.03
F4	99.2	−2.83	0.25±0.07
F5	99.92	−0.17	0.26±0.02
F6	100.13	3.16	0.23±0.04
F7	101.34	−2.16	0.202±0.00
F8	103.02	−0.17	0.24±0.00
F10	99.4	−0.17	0.24±0.03
F12	97.11	−4.83	0.35±0.03
F14	97.43	1.83	0.31±0.03
F15	99.92	1.16	0.35±0.04
F16	100.45	3.83	0.29±0.03
F17	104.32	3.83	0.21±0.02
F18	102.09	−4.16	0.24±0.05
F21	99.89	−0.17	0.34±0.05
F22	103.78	−0.83	0.41±0.03
F23	101.22	−2.83	0.39±0.01
F24	100.32	1.83	0.37±0.04